These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10719607)

  • 1. [Rapacuronium: a new, non-depolarizing muscle relaxant for rapid intubation?].
    Busley R; Blobner M; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Feb; 35(2):112-4. PubMed ID: 10719607
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of rapacuronium neuromuscular blockade by clindamycin and magnesium.
    Sloan PA; Rasul M
    Anesth Analg; 2002 Jan; 94(1):123-4, table of contents. PubMed ID: 11772813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1.
    Blobner M; Mirakhur RK; Wierda JM; Wright PM; Olkkola KT; Debaene B; Pendeville P; Engbaek J; Rietbergen H; Sparr HJ
    Br J Anaesth; 2000 Nov; 85(5):724-31. PubMed ID: 11094588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of action of vecuronium after an intubating dose of rapacuronium, vecuronium, or succinylcholine.
    Gan TJ; Madan R; Alexander R; Jhaveri R; El-Moalem H; Weatherwax K; Glass PS
    Anesth Analg; 2001 May; 92(5):1199-202. PubMed ID: 11323346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapacuronium: clinical pharmacology.
    Mirakhur RK; McCourt KC
    Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium.
    Proost JH; Wright PM
    Eur J Anaesthesiol Suppl; 2001; 23():83-9. PubMed ID: 11766253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapacuronium bromide.
    Stump L
    J Perianesth Nurs; 2000 Aug; 15(4):258-9. PubMed ID: 11235463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracheal intubation conditions and cardiovascular effects after modified rapid-sequence induction with sevoflurane-rapacuronium versus propofol-rapacuronium.
    El-Orbany MI; Wafai Y; Joseph NJ; Salem MR
    J Clin Anesth; 2002 Mar; 14(2):115-20. PubMed ID: 11943524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intubating conditions after rapacuronium (Org 9487) and succinylcholine following rapid sequence induction in adult patients.
    Sparr HJ; Mellinghoff H; Blobner M; Nöldge-Schomburg G
    Br J Anaesth; 1999 Apr; 82(4):537-41. PubMed ID: 10472218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged duration of neuromuscular block with rapacuronium in the presence of sevoflurane.
    Cara DM; Armory P; Mahajan RP
    Anesth Analg; 2000 Dec; 91(6):1392-3, TOC. PubMed ID: 11093986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of neuromuscular effects, tracheal intubating conditions, and reversibility of rapacuronium versus mivacurium in female patients.
    Vanacker BF; Geerts E; Coppens S; van Iersel M
    Anesth Analg; 2002 Apr; 94(4):876-8, table of contents. PubMed ID: 11916789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the intubation conditions provided by rapacuronium (ORG 9487) or succinylcholine in humans during anesthesia with fentanyl and propofol.
    Fleming NW; Chung F; Glass PS; Kitts JB; Kirkegaard-Nielsen H; Gronert GA; Chan V; Gan TJ; Cicutti N; Caldwell JE
    Anesthesiology; 1999 Nov; 91(5):1311-7. PubMed ID: 10551582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of the muscle relaxant for rapid-sequence induction.
    Sparr HJ
    Eur J Anaesthesiol Suppl; 2001; 23():71-6. PubMed ID: 11766251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular rapacuronium in infants and children: dose-ranging and tracheal intubating conditions.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 1999 Nov; 91(5):1285-92. PubMed ID: 10551578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapacuronium: first experience in clinical practice.
    Bartkowski RR; Witkowski TA
    Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-ranging study of rapacuronium in pediatric patients.
    Meakin GH; Meretoja OA; Motsch J; Taivainen T; Wirtavuori K; Schönstedt R; Perkins R; McCluskey A
    Anesthesiology; 2000 Apr; 92(4):1002-9. PubMed ID: 10754619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholine.
    Miguel R; Witkowski T; Nagashima H; Fragen R; Bartkowski R; Foldes FF; Shanks C
    Anesthesiology; 1999 Dec; 91(6):1648-54. PubMed ID: 10598606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rapacuronium on respiratory function during general anesthesia: a comparison with cis-atracurium.
    Tobias JD; Johnson JO; Sprague K; Johnson G
    Anesthesiology; 2001 Oct; 95(4):908-12. PubMed ID: 11605931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapacuronium for neuromuscular blockade in two myasthenic patients undergoing trans-sternal thymectomy.
    Baraka AS; Taha SK; Rizk MS; Rachid-Chehab I; Jalbout MI; Bizri SH
    Eur J Anaesthesiol; 2001 Nov; 18(11):778-80. PubMed ID: 11580788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.